"10.1371_journal.pone.0138341","plos one","2015-09-30T00:00:00Z","Alain Hendlisz; Amelie Deleporte; Thierry Delaunoit; Raphaël Maréchal; Marc Peeters; Stéphane Holbrechts; Marc Van den Eynde; Ghislain Houbiers; Bertrand Filleul; Jean-Luc Van Laethem; Sarah Ceyssens; Anna-Maria Barbuto; Renaud Lhommel; Gauthier Demolin; Camilo Garcia; Hazem El Mansy; Lieveke Ameye; Michel Moreau; Thomas Guiot; Marianne Paesmans; Martine Piccart; Patrick Flamen","Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Oncology Department, Jolimont Hospital, Haine-St-Paul, Belgium; Gastroenterology Medico-Surgical Department, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium; Oncology Department, Antwerp University Hospital, Antwerp University, Edegem, Belgium; Nuclear Medicine Department, Antwerp, University Hospital, Edegem, Belgium; Oncology Department, CHU Ambroise Pare, Mons, Belgium; Oncology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium; Nuclear Medicine Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium; Gastroenterology Department, CHC ST Joseph, Liege, Belgium; Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Data centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium","Conceived and designed the experiments: AH AD M. Paesmans M. Piccart PF. Performed the experiments: AH AD TD RM MP SH MVDE GH BF JLVL SC AMB RL GD CG HEM LA MM TG M. Paesmans M. Piccart PF. Analyzed the data: AH AD CG HEM LA MM TG M. Paesmans M. Piccart PF. Contributed reagents/materials/analysis tools: AH LA M. Paesmans TG CG PF. Wrote the paper: AH AD TD RM MP SH MVDE GH BF JLVL SC AMB RL GD CG HEM LA MM TG M. Paesmans M. Piccart PF.","The authors of this manuscript have read the journal's policy and have the following competing interests: Institut Jules Bordet sponsored this study. Bayer Healthcare AG funded this study by furnishing both a grant and sorafenib but played no further role. AH, PF, M. Paesmans, LA, MM had access to the raw data. The corresponding author had the final responsibility to submit for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AH played an advisory role and received honoraria from Sirtex, Roche, Bayer, Sanofi and Amgen; M. Paesmans played an advisory role and received honoraria from Merck, Roche, Bayer, Sanofi and Amgen; M. Piccart played an advisory role and received honoraria from Roche & Bayer; PF played an advisory role and received honoraria from Sirtex, Roche, Bayer. All other co-authors have no conflicts of interest to disclose. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials","2015","09","Alain Hendlisz","AH",22,TRUE,3,20,8,20,TRUE,TRUE,TRUE,1,"22",TRUE
